The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
59th ASH Annual Meeting & Exposition: abstract submission deadline 2nd August
The 59th American Society of Hematology (ASH) Meeting and Exposition will take place in Atlanta, Georgia, USA, from 9th – 12th December 2017. Abstract submission is due to close on Wednesday 2nd August , 11:59 p.m. (Pacific Time); with the call for late-breaking abstract submissions from 20th – 30th October. Registration opened for ASH members on July 19th and will open to non-members on 9thAugust, 11:00 a.m. Eastern Time; the registration deadline is 1st November. To learn more about the meeting, you can download the preliminary program or visit the official conference website.
The meeting is described by ASH as, “The premier event in malignant and non-malignant hematology”, and will showcase the best scientific research in these fields. The conference will include standard oral sessions of the best selected abstracts, poster sessions, as well as ‘scientific spotlight sessions’ and the opportunity to ‘meet the scientist’. Smaller ‘special interest sessions’ have been scheduled targeting both scientists and practicing hematologists, covering topics such as ‘How to Get published in a Peer-Reviewed Journal’ as well as a special education session on ‘New ASH Clinical Practice Guidelines on Venous Thromboembolism (VTE)’, and a networking reception for female hematologists. Such sessions will contribute to an all-round educational experience, with numerous training opportunities available, in addition to the opportunity to meet with leading scientific researchers and clinicians from a global community of more than 25,000 attendees.
The Multiple Myeloma Hub will be covering key highlights from ASH 2017 including oral sessions, late breaking abstracts, video interviews with key thought leaders and educational sessions, with a focus on the latest MM research that impacts clinical practice.
References